Artículo

Este artículo es de Acceso Abierto y puede ser descargado en su versión final desde nuestro repositorio
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Abstract:

Leukemia inhibitory factor (LIF) and oncostatin M (OSM) induce DNA synthesis in Swiss 3T3 cells through common signaling mechanism(s), whereas other related cytokines such as interleukin-6 and ciliary neurotrophic factor do not cause this response. Induction of DNA replication by LIF or prostaglandin F 2α (PGF 2α) occurs, in part, through different signaling events. LIF and OSM specifically trigger STAT1 cytoplasmic to nuclear translocation, whereas PGF 2α fails to do so. However, LIF and PGF 2α can trigger increases in ERK1/2 activity, which are required for their mitogenic responses because U0126, a MEK1/2 inhibitor, prevents both ERK1/2 activation and induction of DNA synthesis by LIF or PGF 2α treatment. PGF 2α induces cyclin D expression and full phosphorylation of retinoblastoma protein. In contrast, LIF fails to promote increases in cyclin D mRNA/protein levels; consequently, LIF induces DNA synthesis without promoting full phosphorylation of retinoblastoma protein (Rb). However, both LIF and PGF 2α increase cyclin E expression. Furthermore, LIF mitogenic action does not involve protein kinase C (PKC) activation, because a PKC inhibitor does not block this effect. In contrast, PKC activity is required for PGF 2α mitogenic action. More importantly, the synergistic effect between LIF and PGF 2α to promote S phase entry is independent of PKC activation. These results show fundamental differences between LIF and PGF 2α-dependent mechanism(s) that induce cellular entry into S phase. These findings are critical in understanding how LIF and other related cytokine-regulated events participate in normal cell cycle control and may also provide clues to unravel crucial processes underlying cancerous cell division. © 2006 by The American Society for Biochemistry and Molecular Biology, Inc.

Registro:

Documento: Artículo
Título:Leukemia inhibitory factor induces DNA synthesis in Swiss mouse 3T3 cells independently of cyclin D1 expression through a mechanism involving MEK/ERK1/2 activation
Autor:Dekanty, A.; Sauane, M.; Cadenas, B.; Coluccio, F.; Barrio, M.; Casala, J.; Paciencia, M.; Rogers, F.; Coso, O.A.; Piwien-Pilipuk, G.; Rudland, P.S.; Jiménez De Asúa, L.
Filiación:Fundación Instituto Leloir, Av. Patricias Argentinas 435, 1405 Buenos Aires, Argentina
Laboratorio de Fisiología Y Biología Molecular, Facultad de Ciencias Exactas Y Naturales, Universidad de Buenos Aires, 1428 Buenos Aires, Argentina
Molecular Medicine Group, School of Biological Sciences, University of Liverpool, Liverpool L69 3BX, United Kingdom
National Research Council (CONICET) of Argentina, Argentina
Fundación Instituto Leloir, Av. Patricias Argentinas 435, C1405BWE Buenos Aires, Argentina
Royal Society of London, School of Biological Sciences, University of Liverpool, Liverpool, United Kingdom
Palabras clave:Leukemia; Phosphorylation; Translocation; Biosynthesis; Cells; Cytology; Diseases; Enzyme inhibition; DNA; cyclin D; cyclin D1; cyclin E; leukemia inhibitory factor; messenger RNA; mitogen activated protein kinase 1; mitogen activated protein kinase 3; mitogen activated protein kinase kinase 1; STAT1 protein; uo 126; cyclin G; cycline; cytokine; interleukin 6; leukemia inhibitory factor; Lif protein, mouse; mitogen activated protein kinase; mitogen activated protein kinase kinase; oncostatin M; Osm protein, mouse; prostaglandin F2 alpha; protein kinase C; protein tyrosine kinase; retinoblastoma protein; STAT protein; animal cell; animal tissue; article; cell cycle; cell cycle S phase; cell division; cell strain 3T3; controlled study; DNA replication; DNA synthesis; mitogenesis; mouse; nonhuman; phosphorylation; priority journal; protein analysis; protein expression; protein function; protein induction; retinoblastoma; signal transduction; animal; biosynthesis; DNA replication; enzyme activation; genetics; kinetics; metabolism; physiology; Animals; Cyclin D1; Cyclins; Cytokines; Dinoprost; DNA Replication; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Interleukin-6; Kinetics; Leukemia Inhibitory Factor; Mice; Mitogen-Activated Protein Kinase Kinases; Oncostatin M; Phosphorylation; Protein Kinase C; Protein-Tyrosine Kinases; Retinoblastoma Protein; S Phase; Signal Transduction; STAT Transcription Factors; Swiss 3T3 Cells
Año:2006
Volumen:281
Número:10
Página de inicio:6136
Página de fin:6143
DOI: http://dx.doi.org/10.1074/jbc.M505839200
Título revista:Journal of Biological Chemistry
Título revista abreviado:J. Biol. Chem.
ISSN:00219258
CODEN:JBCHA
CAS:cyclin D, 146587-97-5; mitogen activated protein kinase 1, 137632-08-7; mitogen activated protein kinase 3, 137632-07-6; mitogen activated protein kinase, 142243-02-5; mitogen activated protein kinase kinase, 142805-58-1; oncostatin M, 106956-32-5; prostaglandin F2 alpha, 551-11-1; protein kinase C, 141436-78-4; protein tyrosine kinase, 80449-02-1; Cyclin D1, 136601-57-5; Cyclins; Cytokines; Dinoprost, 551-11-1; Extracellular Signal-Regulated MAP Kinases, 2.7.1.37; Interleukin-6; Leukemia Inhibitory Factor; Lif protein, mouse; Mitogen-Activated Protein Kinase Kinases, 2.7.1.-; Oncostatin M, 106956-32-5; Osm protein, mouse; Protein Kinase C, 2.7.1.37; Protein-Tyrosine Kinases, 2.7.1.112; Retinoblastoma Protein; STAT Transcription Factors; cyclin G
PDF:https://bibliotecadigital.exactas.uba.ar/download/paper/paper_00219258_v281_n10_p6136_Dekanty.pdf
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00219258_v281_n10_p6136_Dekanty

Referencias:

  • Williams, R.L., Hilton, D.J., Pease, S., Willson, T.A., Stewart, C.L., Gearing, D.P., Wagner, E.F., Gough, N.M., (1988) Nature, 336, pp. 684-687
  • Hilton, D.J., Gough, N.M., (1991) J. Cell. Biochem., 46, pp. 21-26
  • Hilton, D.J., (1992) Trends Biochem. Sci., 17, pp. 72-76
  • Yoshimura, A., Ichihara, M., Kiniyo, I., Moriyama, M., Copeland, N.G., Gilbert, D.J., Jenkins, N.A., Miyajima, A., (1996) EMBO J., 15, pp. 1055-1063
  • Matsui, Y., Zsebo, K., Hogan, B.L., (1992) Cell, 70, pp. 841-847
  • Grounds, M.D., Yablonca-Reuveni, Z., (1993) Molecular and Cell Biology of Muscular Dystrophy, pp. 120-256. , Partridge, T. A., ed Chapman and Hall Ltd., London
  • Murphy, M., Reid, K., Hilton, D.J., Bartlett, P.F., (1991) Proc. Natl. Acad. Sci. U. S. A., 88, pp. 3498-3501
  • Ip, N.Y., Nye, S.H., Boulton, T.G., Davis, S., Taga, T., Yanping, L.I., Birren, S.J., Yancopulos, G.D., (1992) Cell, 69, pp. 1121-1132
  • Harbour, J.W., Luo, R.X., Dei Santi, A., Postigo, A., Dean, D., (1999) Cell, 98, pp. 859-869
  • Butzkueven, H., Zhang, J.G., Soilu-Hanninen, M., Hochrein, H., Chionh, F., Shipham, K.A., Emery, B., Kilpatrick, T.J., (2002) Nat. Med., 8, pp. 613-619
  • Dazai, S., Akira, S., Hirano, A., Rashid, M.A., Naito, S., Akino, K., Fujii, T., (2000) J. Craniofacial Surg., 11, pp. 513-520
  • Grounds, M.D., (1991) Pathol. Res. Pract., 187, pp. 1-22
  • Stewart, C.L., Kaspar, P., Brunet, L.J., Bhatt, H., Gadi, I., Kontgen, F., Abbondanzo, S.J., (1992) Nature, 359, pp. 76-79
  • Cullinan, E.B., Abbondanzo, S.J., Anderson, P.S., Pollard, J.W., Lessey, B.A., Stewart, C.L., (1996) Proc. Natl. Acad. Sci. U. S. A., 93, pp. 3115-3120
  • Ichikawa, Y., (1969) J. Cell. Physiol., 74, pp. 223-234
  • Ichikawa, Y., (1970) J. Cell. Physiol., 76, pp. 175-184
  • Gearing, D.P., Gough, N.M., King, J.A., Hilton, D.J., Nicola, N.A., Simpson, R.J., Nice, E.C., Metcalf, D., (1987) EMBO J., 6, pp. 3995-4002
  • Moreau, J.F., Donaldson, D.D., Bennett, F., Witek-Gianno, J., Clark, S., Wong, G.G., (1988) Nature, 336, pp. 690-692
  • Schere Levy, C., Buggiano, V., Quaglino, A., Gatelli, A., Cirio, C., Piazzon, I., Vanzulli, S., Kordon, E.C., (2003) Exp. Cell Res., 282, pp. 35-47
  • Minami, M., Inoue, M., Wei, S., Takeda, K., Matsumoto, M., Kishimoto, T., Akira, S., (1996) Proc. Natl. Acad. Sci. U. S. A., 93, pp. 3963-3966
  • Mui, A.L., Wakao, H., Kinoshita, T., Kitamura, T., Miyajima, A., (1996) EMBO J., 15, pp. 2425-2433
  • Schienmann, W.P., Nathanson, N.M., (1998) Oncogene, 16, pp. 2671-2679
  • Yin, T., Yang, Y.C., (1994) J. Biol. Chem., 269, pp. 3731-3738
  • Boulton, T.G., Stahl, N., Yancopoulos, G.D., (1994) J. Biol. Chem., 269, pp. 11648-11655
  • Levy, C.S., Sauane, M., Rudland, P.S., Jiménez De Asúa, L., (1997) Biochem. Biophys. Res. Commun., 236, pp. 814-818
  • Lavoie, J.N., L'Allemain, G., Brunet, A., Muller, R., Pouyssegur, J., (1996) J. Biol. Chem., 271, pp. 20608-20616
  • Sewing, A., Wiseman, B., Lloyd, A.C., Land, H., (1997) Mol. Cell. Biol., 17, pp. 5588-5597
  • Woods, D., Parry, D., Cherwinski, H., Bosch, E., Lees, E., McMahon, M., (1997) Mol. Cell. Biol., 17, pp. 5598-6111
  • Cheng, M., Sexl, V., Sherr, C.J., Roussel, M.F., (1998) Proc. Natl. Acad. Sci. U. S. A., 95, pp. 1091-1096
  • Jiménez De Asúa, L., Goin, M., (1992) FEBS Lett., 299, pp. 235-238
  • De Gomez Alzaga, M., Goin, M., Ortiz, M., Jimenez De Asua, L., (1994) FEBS Lett., 356, pp. 21-24
  • Sauane, M., Coso, O.A., Giulianelli, S., Giráldez, A.N., Rudland, P.S., De Jimenez Asúa, L., (2004) Biochem. Biophys. Res. Commun., 313, pp. 926-930
  • Jiménez De Asúa, L., Richmond, K.M.V., Otto, A.M., (1981) Proc. Natl. Acad. Sci. U. S. A., 78, pp. 1004-1008
  • Otto, A.M., Nilsen-Hamilton, M., Boss, B.D., Ulrich, M.O., Jiménez De Asúa, L., (1982) Proc. Natl. Acad. Sci. U. S. A., 79, pp. 4992-4996
  • Coso, O.A., Chiariello, M., Kalinec, G., Kyriakis, J.M., Woodgett, J., Gutkind, J.S., (1995) J. Biol. Chem., 270, pp. 5620-5624
  • Sauane, M., Correa, L., Rogers, F., Krasnapolski, M., Barraclough, R., Rudland, P., Jiménez De Asúa, L., (2000) Biochem. Biophys. Res. Commun., 270, pp. 11-16
  • Pages, G., Lenormand, P., L'Allemain, G., Chamgard, J.C., Meloche, S., Poyssegur, J., (1993) Proc. Natl. Acad. Sci. U. S. A., 90, pp. 8319-8323
  • Favata, M.F., Horiuchi, K.Y., Manos, E.J., Daulerio, A.J., Stradley, D.A., Feeser, W.S., Van Dyk, D.E., Trzaskos, J.M., (1998) J. Biol. Chem., 273, pp. 18623-18632
  • Balhoff, J.P., Stephens, J.M., (1998) Biochem. Biophys. Res. Commun., 247, pp. 894-900
  • Gould, K.L., Hunter, T., (1988) Mol. Cell. Biol., 8, pp. 3345-3356
  • Davies, S.P., Reddy, H., Caivano, M., Cohen, P., (2000) Biochem. J., 351, pp. 95-105
  • Haspel, R.L., Salditt-Georgieff, M., Darnell Jr., J.E., (1996) EMBO J., 22, pp. 6262-6268
  • Pines, J., Hunter, T., (1995) Cell Cycle Control, pp. 144-176. , Hutchinson, C., and Glover, D. M., eds IRL Press at Oxford University Press, Oxford, UK
  • Sherr, C.J., Roberts, J.M., (1999) Genes Dev., 13, pp. 1501-1512
  • Delehedde, M., Sergeant, N., Lyon, M., Rudland, P.S., Fernig, D.G., (2001) Eur. J. Biochem., 268, pp. 4423-4429
  • Grammer, T.C., Blenis, J., (1997) Oncogene, 14, pp. 1635-1642
  • Stancato, L.F., Sakatsume, M., David, M., Dent, P., Dong, F., Petricoin, E.F., Krolewski, J.J., Larner, A.C., (1997) Mol. Cell. Biol., 17, pp. 3833-3840
  • Balmano, K., Cook, S.J., (1999) Oncogene, 18, pp. 3085-3097
  • Weber, J.D., Raben, D.M., Phillips, P.J., Baldassare, J.J., (1997) Biochem. J., 326, pp. 61-68
  • Gascan, H., Godard, A., Ferenz, C., Naulet, J., Praloran, V., Peyrat, M.A., Hewick, R., Soulillou, J.P., (1989) J. Biol. Chem., 264, pp. 21509-21515
  • Gascan, H., Anegon, I., Praloran, V., Naulet, J., Godard, A., Soulillou, J.P., Jacques, Y., (1990) J. Immunol., 144, pp. 2592-2598
  • Bowman, T., Garcia, R., Turkson, J., Jove, R., (2000) Oncogene, 19, pp. 2474-2488
  • Bromberg, J., Darnell Jr., J.E., (2000) Oncogene, 19, pp. 2468-2473
  • Pines, J., (1997) Oncogenes and Tumor Suppressors, pp. 189-231. , Peters, G., and Vousden, K. H., eds IRL Press at Oxford University Press, Oxford
  • Winston, J.T., Pledger, W.J., (1993) Mol. Biol. Cell., 4, pp. 1133-1144
  • Savatier, P., Lapillonne, H., Van Grunsen, L.A., Rudkin, B.B., Samarut, J., (1996) Oncogene, 12, pp. 309-322
  • Weinberg, R.A., (1995) Cell, 81, pp. 323-330
  • Geng, Y., Whoriskey, W., Park, M.Y., Bronson, R.T., Medema, R.H., Li, T., Weinberg, R.A., Sicinski, P., (1999) Cell, 97, pp. 767-777
  • Lukas, J., Herzinger, T., Hansen, K., Moroni, M.C., Resnitzky, D., Helin, K., Reed, S.I., Bartek, J., (1997) Genes Dev., 11, pp. 1479-1492
  • Santoni-Rugiu, E., Falck, J., Mailand, N., Bartek, J., Lukas, J., (2000) Mol. Cell. Biol., 20, pp. 3497-3509
  • Blomberg, I., Hoffmann, I., (1999) Mol. Cell. Biol., 19, pp. 6183-6194
  • Kozar, K., Ciemerych, M.A., Rebel, V.I., Shigematsu, H., Zagozdzon, A., Sicinska, E., Geng, Y., Sicinski, P., (2004) Cell, 118, pp. 477-491
  • Lundberg, A.S., Weinberg, R.A., (1998) Mol. Cell. Biol., 1, pp. 753-761

Citas:

---------- APA ----------
Dekanty, A., Sauane, M., Cadenas, B., Coluccio, F., Barrio, M., Casala, J., Paciencia, M.,..., Jiménez De Asúa, L. (2006) . Leukemia inhibitory factor induces DNA synthesis in Swiss mouse 3T3 cells independently of cyclin D1 expression through a mechanism involving MEK/ERK1/2 activation. Journal of Biological Chemistry, 281(10), 6136-6143.
http://dx.doi.org/10.1074/jbc.M505839200
---------- CHICAGO ----------
Dekanty, A., Sauane, M., Cadenas, B., Coluccio, F., Barrio, M., Casala, J., et al. "Leukemia inhibitory factor induces DNA synthesis in Swiss mouse 3T3 cells independently of cyclin D1 expression through a mechanism involving MEK/ERK1/2 activation" . Journal of Biological Chemistry 281, no. 10 (2006) : 6136-6143.
http://dx.doi.org/10.1074/jbc.M505839200
---------- MLA ----------
Dekanty, A., Sauane, M., Cadenas, B., Coluccio, F., Barrio, M., Casala, J., et al. "Leukemia inhibitory factor induces DNA synthesis in Swiss mouse 3T3 cells independently of cyclin D1 expression through a mechanism involving MEK/ERK1/2 activation" . Journal of Biological Chemistry, vol. 281, no. 10, 2006, pp. 6136-6143.
http://dx.doi.org/10.1074/jbc.M505839200
---------- VANCOUVER ----------
Dekanty, A., Sauane, M., Cadenas, B., Coluccio, F., Barrio, M., Casala, J., et al. Leukemia inhibitory factor induces DNA synthesis in Swiss mouse 3T3 cells independently of cyclin D1 expression through a mechanism involving MEK/ERK1/2 activation. J. Biol. Chem. 2006;281(10):6136-6143.
http://dx.doi.org/10.1074/jbc.M505839200